Literature DB >> 24300418

The rhinitis control assessment test: implications for the present and future.

Robert A Nathan1.   

Abstract

PURPOSE OF REVIEW: To summarize the development of the Rhinitis Control Assessment Test (RCAT), its usefulness in clinical practice, and the benefit it provides for patients who are bothered by allergic and nonallergic rhinitis. RECENT
FINDINGS: The RCAT, a simple, brief, self-administered questionnaire, was developed to assist physicians in the assessment of patient's rhinitis control in clinical practice. It was also to help patients appreciate what rhinitis control is. The RCAT generates a rhinitis score that can be easily understood and is appropriate for long-term monitoring of rhinitis control.
SUMMARY: Rhinitis control remains an elusive goal for physicians and patients. Having a patient-rated screening instrument, like the RCAT, to assist in achieving this goal was felt to be important. If used appropriately, it reflects the multidimensional aspect of rhinitis control. It should also result in an improvement in the quality of care for patients with rhinitis.

Entities:  

Mesh:

Year:  2014        PMID: 24300418     DOI: 10.1097/ACI.0000000000000020

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  5 in total

Review 1.  An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel.

Authors:  Brian Lipworth; Jon Newton; Bhaskar Ram; Iain Small; Jürgen Schwarze
Journal:  NPJ Prim Care Respir Med       Date:  2017-01-23       Impact factor: 2.871

2.  Fermented red ginseng and ginsenoside Rd alleviate ovalbumin-induced allergic rhinitis in mice by suppressing IgE, interleukin-4, and interleukin-5 expression.

Authors:  Hye In Kim; Jeon-Kyung Kim; Jae-Young Kim; Myung Joo Han; Dong-Hyun Kim
Journal:  J Ginseng Res       Date:  2019-03-07       Impact factor: 6.060

3.  Pediatric asthma control during the COVID-19 pandemic.

Authors:  Valentina Agnese Ferraro; Andrea Zamunaro; Silvia Spaggiari; Daniela Di Riso; Stefania Zanconato; Silvia Carraro
Journal:  Immun Inflamm Dis       Date:  2021-03-03

4.  Efficacy and Safety of Modified Yupingfeng Nasal Spray in Controlling the Recurrence of Persistent and Moderate-Severe Allergic Rhinitis: Study Protocol for a Multicenter, Open-Label, Randomized, and Parallel-Arm Trial.

Authors:  Ting Liu; Bing-Qing Lu; Dan-Dan Wang; Chao Liao; Han-Jen Chiang; Rong Zhang; Yuan Xi; Li Tian
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-10       Impact factor: 2.650

5.  Correlation of the combined symptom and medication score with quality of life, symptom severity and symptom control in allergic rhinoconjunctivitis.

Authors:  Binoy Palathumpattu; Ursula Pieper-Fürst; Cengizhan Acikel; Hacer Sahin; Silke Allekotte; Jaswinder Singh; Mark Hess; Angelika Sager; Thomas Müller; Ralph Mösges
Journal:  Clin Transl Allergy       Date:  2022-10-05       Impact factor: 5.657

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.